NCT03276442

Brief Summary

Metabolism is increasingly recognized as being highly regulated by anticipatory biological rhythms (circadian rhythms or "biorhythms"), which are driven by molecular feedback loops, and which are approximately 24 hours long ("circa diem"). These circadian rhythms exist both centrally, in the brain, but also in the periphery, and are specific to many tissues depending on their main biological function or functions. Whereas these circadian rhythms have been thoroughly characterized in other organisms, their role in humans remain poorly understood, partly because of the difficulty in studying these rhythms in peripheral tissues. The investigators therefore aim to characterize these rhythms in primarily skeletal muscle and adipose tissue in healthy young volunteers (using the so-called constant routine paradigm), and how these rhythms interact with one another at various genetic and molecular levels. At the same time, the investigators aim to study how an unhealthy vs. healthy diet can alter these circadian rhythms, and how they interact with circadian rhythms in other tissue compartments such as those expressed by blood cells.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

August 31, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

October 12, 2017

Status Verified

October 1, 2017

Enrollment Period

2.2 years

First QC Date

August 28, 2017

Last Update Submit

October 10, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in clock gene & associated omic circadian rhythms

    Changes in clock gene \& associated clock-regulated \& clock-independent metabolic and omic circadian rhythms (e.g. in epigenome, transcriptome, metabolites) in peripheral tissues (primarily skeletal muscle and adipose tissue), and interplay between these rhythms across the 24-h period and under the different dietary conditions

    Measured repeatedly (every 6 hours for 24 hours) during a period of extended wakefulness, following each dietary intervention (i.e. over a total period of 6-7 weeks)

Secondary Outcomes (8)

  • Wakefulness-induced changes and subsequent recovery at omic levels

    Following each dietary intervention (i.e. over a total period of 6-7 weeks), measured repeatedly (every 2-6 hours for 24 hours) during a period of extended wakefulness, and after recovery sleep

  • 24-h rhythms in blood

    Measured repeatedly (every 2-3 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)

  • Diet-induced changes in gut microbiota and relation to circadian rhythms

    Measured throughout study participation, i.e. on average over 6-7 weeks

  • Energy expenditure rhythms

    Measured repeatedly (every 2 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)

  • Urine metabolite rhythms

    Measured throughout study participation, i.e. on average over 6-7 weeks

  • +3 more secondary outcomes

Study Arms (2)

Healthy diet

EXPERIMENTAL

'Low-fat dietary intervention' to be administered to participants

Other: Low-fat dietary intervention

Unhealthy diet

EXPERIMENTAL

'High-fat dietary intervention' to be administered to participants

Other: High-fat dietary intervention

Interventions

Low-fat diet (5-7 days) preceding extended wakefulness under standardized conditions

Healthy diet

High-fat diet (5-7 days) preceding extended wakefulness under standardized conditions

Unhealthy diet

Eligibility Criteria

Age18 Years - 32 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-33 yr
  • Healthy (self-reported) and not on medication
  • BMI 18-28 kg/m2 (and waist circumference \<102 cm), and weight stable (±5% body weight in past 6 months)
  • Non-smoker and non-nicotine user
  • Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night
  • Sedentary to moderately active with regular exercise habits the last 2 months
  • Regular daily meal pattern with 3 main meals

You may not qualify if:

  • Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease
  • Current or history of endocrine or metabolic disorders
  • Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy)
  • Frequent gastrointestinal symptoms
  • Chronic medication
  • Any sleep disorder (e.g. irregular bedtimes, symptoms of insomnia)
  • Any issues with or allergies against the provided food items or utilized anesthesia
  • Shift work in the preceding three months or for a long duration
  • Time travel over two time zones in the preceding month
  • Too much weight gain or weight loss in the preceding 6 months
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neuroscience, Uppsala University

Uppsala, 75324, Sweden

RECRUITING

Related Publications (1)

  • Brandao LEM, Popa A, Cedernaes E, Cedernaes C, Lampola L, Cedernaes J. Exposure to a more unhealthy diet impacts sleep microstructure during normal sleep and recovery sleep: A randomized trial. Obesity (Silver Spring). 2023 Jul;31(7):1755-1766. doi: 10.1002/oby.23787. Epub 2023 May 28.

MeSH Terms

Conditions

Sleep Deprivation

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Jonathan Cedernaes

    Uppsala University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jonathan Cedernaes, M.D., Ph.D.

CONTACT

Christian Benedict, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
In the crossover subgroup condition, participants will not be briefed about what diet they will receive before the actual onset of the dietary intervention
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants will be studied in a crossover design both after a "healthy diet", and after an "unhealthy diet"
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2017

First Posted

September 8, 2017

Study Start

August 31, 2017

Primary Completion

November 30, 2019

Study Completion

December 31, 2019

Last Updated

October 12, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations